Canland Health Announces Non-Brokered Private Placement

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

VANCOUVER, BC / ACCESSWIRE / October 29, 2019 / Canland Health Corp. (the “Company”) today announced that it intends to arrange the placement of up to 2,120,000 common shares priced at $0.25 per common share for total gross proceeds of up to $530,000 (the “Offering”). Proceeds from the Offering and prior financings shall be used for investigating project acquisitions and general corporate purposes. The Offering is subject to regulatory approval and all securities to be issued pursuant to the Offering are subject to a four-month hold period under applicable Canadian securities laws.

For further information regarding this news release contact:

C.K. Cheung, CEO
Tel: 416 904 1478

On behalf of the Board of Directors
CANLAND HEALTH CORP.

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO SELL ANY OF THE SECURITIES DESCRIBED HEREIN IN THE UNITED STATES. THESE SECURITIES HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE UNITED STATED SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

SOURCE: Canland Health Corp.

View source version on accesswire.com:
https://www.accesswire.com/564593/Canland-Health-Announces-Non-Brokered-Private-Placement

Staff

Recent Posts

Hisense Unveils Latest AI-Driven Innovations at AWE 2025, Pioneering a New Era of Smart Living

DUBAI, UAE, March 27, 2025 /PRNewswire/ -- Hisense, a leading global consumer electronics brand showcased…

31 minutes ago

DeepCare Unveils Game-Changing Dental AI Agent at IDS 2025

COLOGNE, Germany, March 27, 2025 /PRNewswire/ -- From March 25 to 29, 2025, DeepCare, a global…

31 minutes ago

Ventra Health Launches Strategic Partnership with Radix Health to Offer Independent Dispute Resolution to Providers

DALLAS, March 26, 2025 /PRNewswire/ -- Ventra Health ("Ventra"), a leading business solutions provider for facility-based…

7 hours ago

Zepp Health Corporation Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results

MILPITAS, Calif., March 26, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:…

13 hours ago

CytoSite Bio Announces Agreement with Lantheus for Granzyme B Targeted PET Imaging Radiotracer for Immunotherapy Assessment

A global collaboration agreement has been signed for the development and commercialization of a Granzyme…

13 hours ago